Prudence Francis, MD, and Hope Rugo, MD, on the Phase III SOFT Trial

2014 San Antonio Breast Cancer Symposium
Tweet this page

Prudence Francis, MD, of Peter MacCallum Cancer Centre, and Hope Rugo, MD, of the University of California, San Francisco, discuss data from abstract S3-08, "Randomized comparison of adjuvant tamoxifen plus ovarian function suppression vs tamoxifen in premenopausal women with hormone receptor–positive early breast cancer: Analysis of the SOFT trial."

Advertisement

Advertisement



Advertisement